Retraction
Clinical trials in Alzheimer's disease': immunotherapy approaches
Paper Information
Record ID:
30541
Journal:
Publication Date:
August 30, 2011
Retraction Date:
July 06, 2021
(4.4 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institution:
Alzheimer’s Disease Clinical Research Centre, Gérontopôle, Toulouse University Hospital, FranceCountry:
🇫🇷 FranceArticle Type:
Publisher:
Wiley
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (145)
145
Total Citations6
Post-Retraction(4.1%)
138
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
5
After 2+ years
1061
Days since retraction (latest)
Paper citing Clinical trials in Alzheimer's disease': immunothe...
Unknown Authors
Unknown Journal
Published: Unknown
A Comprehensive Review on Alzheimer’s Disease; Pathophysiology and Treatment
Nandini Nandini, Kusu Susan Cyriac
International Journal of Pharmaceutical Sciences Review and Research
Open Access
Published: Jun 2024
1061 days after retraction
Alzheimer’s disease: Systematic review of recent substantial therapeutic targets
Nikita Sharma, Manpreet Kaur Aulakh
AIP conference proceedings
Published: Jan 2024
909 days after retraction
Modulation of Cytosolic Phospholipase A2 as a Potential Therapeutic Strategy for Alzheimer’s Disease
Séverine André, Sébastien Verteneuil, Laurence Ris et al. (10 authors)
Journal of Alzheimer s Disease Reports
Open Access
Published: Nov 2023
848 days after retraction
Recent Updates on the Development of Therapeutics for the Targeted Treatment of Alzheimer’s Disease
Shivam Rajput, Rishabha Malviya, Shiv Bahadur et al. (4 authors)
Current Pharmaceutical Design
Published: Oct 2023
3 citations
3 citations
817 days after retraction
Understanding Alzheimer’s Disease and its Metal Chelation Therapeutics: A Narrative Review
Ritik Thakur, Ritu Karwasra, Tarana Umar
Current Pharmaceutical Design
Published: Aug 2023
3 citations
3 citations
756 days after retraction
Beneficial Effect of ACI-24 Vaccination on Aβ Plaque Pathology and Microglial Phenotypes in an Amyloidosis Mouse Model
Jasenka Rudan Njavro, Marija Vukicevic, Emma Fiorini et al. (20 authors)
Cells
Open Access
Published: Dec 2022
8 citations
8 citations
536 days after retraction
Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
Teeba Athar, Khalid Al Balushi, Shah Alam Khan
Molecular Biology Reports
Open Access
Published: Jun 2021
194 citations
194 citations
8 days before retraction
Natural and Synthetic Saponins as Vaccine Adjuvants
Pengfei Wang
Vaccines
Open Access
Published: Mar 2021
100 citations
100 citations
123 days before retraction
Alzheimer’s Disease: Perspective on Therapeutic Options and Recent Hallmarks in Clinical Research
Aubine Molly Beera, Sarvan Manikiran Seethamraju, Lakshmi Prasanthi Nori
International Journal Of Pharmaceutical Research And Allied Sciences
Open Access
Published: Jan 2021
6 citations
6 citations
186 days before retraction
A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy
Kundlik Gadhave, Deepak Kumar, Vladimir N. Uversky et al. (4 authors)
Medicinal Research Reviews
Open Access
Published: Aug 2020
52 citations
52 citations
329 days before retraction
Emerging Promise of Immunotherapy for Alzheimer’s Disease: A New Hope for the Development of Alzheimer’s Vaccine
Md. Tanvir Kabir, Md. Sahab Uddin, Bijo Mathew et al. (6 authors)
Current Topics in Medicinal Chemistry
Published: Apr 2020
28 citations
28 citations
439 days before retraction
Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials
Irina Petrushina, Armine Hovakimyan, Indira S. Harahap-Carrillo et al. (18 authors)
Neurobiology of Disease
Open Access
Published: Feb 2020
34 citations
34 citations
494 days before retraction
Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death
Yong Qi Leong, Khuen Yen Ng, Soi Moi Chye et al. (5 authors)
Metabolic Brain Disease
Published: Dec 2019
70 citations
70 citations
578 days before retraction
Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study
Go Akamatsu, Yasuhiko Ikari, Akihito Ohnishi et al. (7 authors)
EJNMMI Research
Open Access
Published: Sep 2019
13 citations
13 citations
657 days before retraction
Carbon nanomaterials and amyloid-beta interactions: potentials for the detection and treatment of Alzheimer's disease?
Mohammad Mohajeri, Behzad Behnam, George E. Barreto et al. (4 authors)
Pharmacological Research
Published: Mar 2019
54 citations
54 citations
828 days before retraction
Xanthohumol inhibits tau protein aggregation and protects cells against tau aggregates
Mohan Zhang, Qiuping Wu, Xuanbao Yao et al. (7 authors)
Food & Function
Published: Jan 2019
27 citations
27 citations
917 days before retraction
Promising Results from Alzheimer’s Disease Passive Immunotherapy Support the Development of a Preventive Vaccine
Dante J. Marciani
Research
Open Access
Published: Jan 2019
30 citations
30 citations
917 days before retraction
Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay
Max Holzer, Nico Schade, Ansgar Opitz et al. (12 authors)
Molecules
Open Access
Published: Sep 2018
23 citations
23 citations
1028 days before retraction
A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer’s disease
Kameran Lashkari, Gianna C Teague, Hong Chen et al. (7 authors)
PLoS ONE
Open Access
Published: May 2018
28 citations
28 citations
1142 days before retraction
A Vaccine Kit for Prevention and Therapy of Alzheimer’s Disease in a Transgenic Mouse Model
Iván Carrera, Carmen Vigo, Ramón Cacabelos
Journal of Exploratory Research in Pharmacology
Open Access
Published: Feb 2018
1 citation
1 citation
1251 days before retraction
Design optimization for clinical trials in early‐stage manifest Huntington's disease
Chris Frost, Amy Mulick, Rachael I. Scahill et al. (14 authors)
Movement Disorders
Open Access
Published: Sep 2017
13 citations
13 citations
1391 days before retraction
Paper citing Clinical trials in Alzheimer's disease': immunothe...
Unknown Authors
Unknown Journal
Published: Jul 2017
1441 days before retraction
A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer’s disease
Shaowei Wang, Dong‐qun Liu, Lingxiao Zhang et al. (9 authors)
Alzheimer s Research & Therapy
Open Access
Published: Jun 2017
13 citations
13 citations
1490 days before retraction
Immunomodulation via Toll-like Receptor 9: An Adjunct Therapy Strategy against Alzheimer's Disease?
María Clara Sellés, Juliana T.S. Fortuna, Luís E. Santos
Journal of Neuroscience
Open Access
Published: May 2017
6 citations
6 citations
1518 days before retraction
Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery
Robert A. McArthur
Neuroscience & Biobehavioral Reviews
Published: Apr 2017
40 citations
40 citations
1537 days before retraction
New Therapeutic Targets in Alzheimer's Disease
Horia Coman, B. Nemeş
International journal of gerontology
Open Access
Published: Feb 2017
56 citations
56 citations
1596 days before retraction
β-Amyloid Prions and the Pathobiology of Alzheimer’s Disease
Joel C. Watts, Stanley B. Prusiner
Cold Spring Harbor Perspectives in Medicine
Open Access
Published: Feb 2017
75 citations
75 citations
1604 days before retraction
Flavonoids in Transgenic Alzheimer's Disease Mouse Models
Angélica María Sabogal-Guáqueta, Edison Osorio, Gloria Patricia Cardona‐Gómez
Unknown Journal
Published: Jan 2017
1 citation
1 citation
1646 days before retraction
Immunotherapy for the Treatment of Alzheimer’s Disease
Akhlaq A. Farooqui
Elsevier eBooks
Published: Jan 2017
1647 days before retraction
Novel Treatment Strategies Using TiO2-Nanowired Delivery of Histaminergic Drugs and Antibodies to Tau With Cerebrolysin for Superior Neuroprotection in the Pathophysiology of Alzheimer's Disease
Aruna Sharma, Preeti K. Menon, Ranjana Patnaik et al. (9 authors)
International review of neurobiology
Published: Jan 2017
26 citations
26 citations
1647 days before retraction
Antioxidants in the Prevention and Treatment of Alzheimer’s Disease
Sandeep Kumar Singh, Saripella Srikrishna, Rudy J. Castellani et al. (4 authors)
Springer eBooks
Published: Jan 2017
13 citations
13 citations
1647 days before retraction
Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer’s Disease
Irina Petrushina, Hayk Davtyan, Armine Hovakimyan et al. (8 authors)
Molecular Therapy
Open Access
Published: Jan 2017
17 citations
17 citations
1647 days before retraction
Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America
Gloria Patricia Cardona‐Gómez, Francisco Lopera
Frontiers in Aging Neuroscience
Open Access
Published: Dec 2016
11 citations
11 citations
1659 days before retraction
Alzheimer’s disease in people with Down’s syndrome: the prospects for and the challenges of developing preventative treatments
Paula Castro, Shahid Zaman, Anthony Holland
Journal of Neurology
Open Access
Published: Oct 2016
49 citations
49 citations
1716 days before retraction
Paper citing Clinical trials in Alzheimer's disease': immunothe...
Unknown Authors
Unknown Journal
Published: Oct 2016
1716 days before retraction
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide
Maria Gregori, Mark Taylor, Elisa Salvati et al. (18 authors)
Nanomedicine Nanotechnology Biology and Medicine
Open Access
Published: Oct 2016
56 citations
56 citations
1721 days before retraction
Reduction of Blood Amyloid-β Oligomers in Alzheimer’s Disease Transgenic Mice by c-Abl Kinase Inhibition
Lisbell D. Estrada, David Chamorro, Maria Yanez et al. (13 authors)
Journal of Alzheimer s Disease
Published: Aug 2016
30 citations
30 citations
1774 days before retraction
Alzheimer’s disease AdvaxCpG- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules
Hayk Davtyan, Karen Zagorski, Harinda Rajapaksha et al. (11 authors)
Scientific Reports
Open Access
Published: Jul 2016
43 citations
43 citations
1831 days before retraction
Probabilistic Cost-Effectiveness Analysis of Vaccination for Mild or Moderate Alzheimer's Disease
Kuen‐Cheh Yang, Chien‐Jen Chen
Current Alzheimer Research
Open Access
Published: May 2016
5 citations
5 citations
1882 days before retraction
High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide
Sabine Rauth, Dominik Hinz, Michael A. Borger et al. (7 authors)
Biochemical Journal
Open Access
Published: Mar 2016
32 citations
32 citations
1923 days before retraction
‘From past to future’ - deciphering the molecular basis of Alzheimer's disease through the pages of the Journal of Neurochemistry
Roberto Cappai
Journal of Neurochemistry
Open Access
Published: Mar 2016
4 citations
4 citations
1933 days before retraction
Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice
Haichao Wang, Yun‐Zhou Yu, Si Liu et al. (5 authors)
Vaccine
Published: Mar 2016
12 citations
12 citations
1952 days before retraction
Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
Andrea Marzi, Aisling A. Murphy, Friederike Feldmann et al. (11 authors)
Scientific Reports
Open Access
Published: Feb 2016
66 citations
66 citations
1968 days before retraction
Paper citing Clinical trials in Alzheimer's disease': immunothe...
Unknown Authors
Unknown Journal
Published: Feb 2016
1968 days before retraction
Mechanism of Anti-α-Synuclein Immunotherapy
Jun Sung Lee, Seung‐Jae Lee
Journal of Movement Disorders
Open Access
Published: Jan 2016
44 citations
44 citations
1989 days before retraction
Neurodegenerative Diseases and Dementia
Christopher Janus, Hans Welzl
Springer eBooks
Published: Jan 2016
2 citations
2 citations
2013 days before retraction
Extracellular α-Synuclein as a Target for Immunotherapy
Jun Sung Lee, Seung‐Jae Lee
Methods in pharmacology and toxicology
Published: Jan 2016
2013 days before retraction
Mapping the Alzheimer’s Disease Clinical Trial Space
Timothy Schultz
Unknown Journal
Published: Jan 2016
2013 days before retraction
Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X
Gregory Antonios, Henning Borgers, Bernhard Clemens Richard et al. (14 authors)
Scientific Reports
Open Access
Published: Dec 2015
51 citations
51 citations
2043 days before retraction
Quick Stats
Total Citations:
145
Years Since Retraction:
4.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025